Affiliation:
1. Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran
2. Department of Dermatology, School of Medicine Razi Hospital Tehran University of Medical Sciences Tehran Iran
3. Department of Dentistry Rafsanjan University of Medical Sciences (RUMS) Rafsanjan Iran
4. Department of Dermatology, Rasool Akram Medical Complex Iran University of Medical Sciences (IUMS) Tehran Iran
5. Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran
6. Department of Dermatology Babol University of Medical Sciences Babol Iran
Abstract
AbstractBackgroundFor decades, the notion that elective surgeries and cutaneous procedures should be postponed for 6–12 months in patients on, or recently administered with isotretinoin, has been widely accepted. However, some recent studies showed the need for a change in this regard.MethodHere, we reviewed the existing data in this regard through searching on PubMed, Google Scholar, and Scopus. All of the relevant papers published in English, until October, 2022, which we could access to their full‐texts, were included.ResultsWe found some recommendations made by plastic surgeons, dermatologists, ENT surgeons, ophthalmologists, orthopedic surgeons, and dentists regarding the correct timing of procedural interventions in patients on, or recently administered with isotretinoin and tried to summarize them to provide a practical guide for clinicians.ConclusionPhysicians may discuss with patients regarding the known risk of abnormal wound healing in the setting of systemic isotretinoin treatment and suggest that, when possible, surgical procedures be postponed until the activity of the retinoids has time to subside. It is even more important regarding patients with darker skin phototypes to follow an even more strict guideline.